Cleveland Biolabs, Inc. (CBLI) Posts Q2 Loss of 7c/Share
Tweet Send to a Friend
Cleveland Biolabs, Inc. (NASDAQ: CBLI) reported Q2 EPS of ($0.07) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
